These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29461635)
1. Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group. Teot LA; Schneider M; Thorner AR; Tian J; Chi YY; Ducar M; Lin L; Wlodarski M; Grier HE; Fletcher CDM; van Hummelen P; Skapek SX; Hawkins DS; Wagers AJ; Rodriguez-Galindo C; Hettmer S Cancer; 2018 May; 124(9):1973-1981. PubMed ID: 29461635 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations. Agaram NP; Huang SC; Tap WD; Wexler LH; Antonescu CR Genes Chromosomes Cancer; 2022 Mar; 61(3):131-137. PubMed ID: 34755412 [TBL] [Abstract][Full Text] [Related]
3. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma. Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669 [TBL] [Abstract][Full Text] [Related]
4. Uncovering metabolism in rhabdomyosarcoma. Monti E; Fanzani A Cell Cycle; 2016; 15(2):184-95. PubMed ID: 26209235 [TBL] [Abstract][Full Text] [Related]
5. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma. Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044 [TBL] [Abstract][Full Text] [Related]
6. Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children. Kazanowska B; Reich A; Stegmaier S; Békássy AN; Leuschner I; Chybicka A; Koscielniak E Fetal Pediatr Pathol; 2007; 26(1):17-31. PubMed ID: 17613043 [TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382 [TBL] [Abstract][Full Text] [Related]
8. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma. Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366 [TBL] [Abstract][Full Text] [Related]
9. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group. Hingorani P; Missiaglia E; Shipley J; Anderson JR; Triche TJ; Delorenzi M; Gastier-Foster J; Wing M; Hawkins DS; Skapek SX Clin Cancer Res; 2015 Oct; 21(20):4733-9. PubMed ID: 26473193 [TBL] [Abstract][Full Text] [Related]
10. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Yasuda T; Perry KD; Nelson M; Bui MM; Nasir A; Goldschmidt R; Gnepp DR; Bridge JA Hum Pathol; 2009 Mar; 40(3):341-8. PubMed ID: 18973919 [TBL] [Abstract][Full Text] [Related]